Replies to post #124 on Repros Therapeutics, Inc. (RPRX)

[Dr Bill]

yeah, it doesn't make any sense


I'm not going to say it's NOT going to $8 again, but I can say with some assurity that it's a VERY safe buy here. Well, as safe as any mid stage biotech company. But still. IF they get any reasonable deal at all for Androxal, say $30M, they're just above cash at that point....

crazy, but then again the market is the most insane schizo there ever was

too bad it can remain out of balance for so long, eh??